<p>, /PRNewswire/ -- DJS 律師事務所提醒投資者，針對 Skye Bioscience, Inc.（&#34;Skye&#34;或&#34;公司&#34;）（NASDAQ: SKYE）提起的集體訴訟，因違反 1934 年證券交易法第 10(b) 條和第 20(a) 條以及美國證券交易委員會制定的第 10b-5 條。</p>
<p>在列出的集體訴訟期間購買 SKYE 股票的股東，鼓勵與本事務所聯繫以討論可能的首席原告任命。被任命為首席原告並不是參與任何賠償的必要條件。</p>
<p>** 集體訴訟期間：**2024 年 11 月 4 日至 2025 年 10 月 3 日</p>
<p>** 截止日期：**2026 年 1 月 16 日</p>
<p><strong>案件詳情：</strong> 根據投訴，公司向市場發佈了虛假和誤導性聲明。Skye 的 nimacimab 未能證明其之前聲稱的有效性。基於這些事實，Skye 在集體訴訟期間的公開聲明是虛假且具有實質性誤導性的。</p>
<p>如果您是遭受損失的股東，請聯繫我們參與。</p>
<p><strong>為什麼選擇 DJS 律師事務所？</strong> DJS 律師事務所的主要關注點是通過平衡的諮詢和積極的倡導來提升投資者回報。我們專注於證券集體訴訟、公司治理訴訟以及國內/國際併購評估。我們的客户是全球一些最大和最複雜的對沖基金和另類資產管理公司。我們客户的訴訟索賠是極其有價值的資產，值得尊重、關注和結果。</p>
<p>加入案件以追回您的損失。</p>
<p>本新聞稿在某些司法管轄區可能被視為律師廣告，依據適用法律和倫理規則。</p>
<p><strong>聯繫方式：</strong> David J. Schwartz</p>
<p>DJS 律師事務所</p>
<p>274 White Plains Road, Suite 1</p>
<p>Eastchester, NY 10709</p>
<p>電話：914-206-9742</p>
<p>電子郵件：[email protected]</p>
<p>來源 DJS 律師事務所 LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE5Jk5ld3NJdGVtSWQ9TEE2NTczMyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTkwMjEzUFJfTkVXU19VU1BSX19fX19MQTY1NzMz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE5Jk5ld3NJdGVtSWQ9TEE2NTczMyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTkwMjEzUFJfTkVXU19VU1BSX19fX19MQTY1NzMz"/></p>

SKYE

<p>DJS 法律集團已宣佈對 Skye Bioscience, Inc.（納斯達克股票代碼：SKYE）提起集體訴訟，指控其違反證券法，特別是對其產品 nimacimab 發佈虛假和誤導性聲明。集體訴訟的時間範圍為 2024 年 11 月 4 日至 2025 年 10 月 3 日，主要原告的任命截止日期為 2026 年 1 月 16 日。在此期間遭受損失的股東被鼓勵聯繫該公司以參與訴訟</p>

<p>, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Skye Bioscience, Inc. (&#34;Skye&#34; or &#34;the Company&#34;) (NASDAQ: SKYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- DJS 律師事務所提醒投資者，針對 Skye Bioscience, Inc.（&#34;Skye&#34;或&#34;公司&#34;）（NASDAQ: SKYE）提起的集體訴訟，因違反 1934 年證券交易法第 10(b) 條和第 20(a) 條以及美國證券交易委員會制定的第 10b-5 條。</p>
</div><p>Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.</p>
<div class="lb-trans"><p>在列出的集體訴訟期間購買 SKYE 股票的股東，鼓勵與本事務所聯繫以討論可能的首席原告任命。被任命為首席原告並不是參與任何賠償的必要條件。</p>
</div><p><strong>CLASS PERIOD:</strong> November 4, 2024 to October 3, 2025</p>
<div class="lb-trans"><p>** 集體訴訟期間：**2024 年 11 月 4 日至 2025 年 10 月 3 日</p>
</div><p><strong>DEADLINE:</strong> January 16, 2026</p>
<div class="lb-trans"><p>** 截止日期：**2026 年 1 月 16 日</p>
</div><p><strong>CASE DETAILS:</strong> According to the Complaint, the Company made false and misleading statements to the market. Skye's nimacimab failed to demonstrate the efficacy it had previously claimed. Based on these facts, Skye's public statements were false and materially misleading throughout the class period.</p>
<div class="lb-trans"><p><strong>案件詳情：</strong> 根據投訴，公司向市場發佈了虛假和誤導性聲明。Skye 的 nimacimab 未能證明其之前聲稱的有效性。基於這些事實，Skye 在集體訴訟期間的公開聲明是虛假且具有實質性誤導性的。</p>
</div><p>If you are a shareholder who suffered a loss, contact us to participate.</p>
<div class="lb-trans"><p>如果您是遭受損失的股東，請聯繫我們參與。</p>
</div><p><strong>WHY DJS LAW GROUP?</strong> DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.</p>
<div class="lb-trans"><p><strong>為什麼選擇 DJS 律師事務所？</strong> DJS 律師事務所的主要關注點是通過平衡的諮詢和積極的倡導來提升投資者回報。我們專注於證券集體訴訟、公司治理訴訟以及國內/國際併購評估。我們的客户是全球一些最大和最複雜的對沖基金和另類資產管理公司。我們客户的訴訟索賠是極其有價值的資產，值得尊重、關注和結果。</p>
</div><p>Join the case to recover your losses.</p>
<div class="lb-trans"><p>加入案件以追回您的損失。</p>
</div><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.</p>
<div class="lb-trans"><p>本新聞稿在某些司法管轄區可能被視為律師廣告，依據適用法律和倫理規則。</p>
</div><p><strong>CONTACT:</strong> David J. Schwartz</p>
<div class="lb-trans"><p><strong>聯繫方式：</strong> David J. Schwartz</p>
</div><p>DJS Law Group</p>
<div class="lb-trans"><p>DJS 律師事務所</p>
</div><p>274 White Plains Road, Suite 1</p>
<div class="lb-trans"><p>274 White Plains Road, Suite 1</p>
</div><p>Eastchester, NY 10709</p>
<div class="lb-trans"><p>Eastchester, NY 10709</p>
</div><p>Phone: 914-206-9742</p>
<div class="lb-trans"><p>電話：914-206-9742</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>電子郵件：[email protected]</p>
</div><p>SOURCE DJS Law Group LLP</p>
<div class="lb-trans"><p>來源 DJS 律師事務所 LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE5Jk5ld3NJdGVtSWQ9TEE2NTczMyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTkwMjEzUFJfTkVXU19VU1BSX19fX19MQTY1NzMz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA65733&amp;Transmission_Id=202601190213PR_NEWS_USPR_____LA65733&amp;DateId=20260119"/></p>

Skye Bioscience, Inc. 因涉嫌違反證券法而被起訴 - 請聯繫 DJS 律師事務所以討論您的權利 - SKYE